Business

Notice of Results & Investor Presentation

Notice of Results & Investor Presentation.

articleEkf Diagnostics Holdings PlcSeptember 14, 20233/company/ekf-diagnostics-holdings-plc/news/notice-of-results-and-investor-presentation-156
Notice of Results & Investor Presentation

About this update from Ekf Diagnostics Holdings Plc

[{"type":"text","content":"\n\nEKF Diagnostics Holdings plc\n(\"EKF\" or the \"Company\")\n \nNotice of Interim Results\n&\nInvestor Presentation\n \nEKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics business, confirms that the Company will announce its interim results for the six months ended 30 June 2023 (\"H1 2023\"), on Tuesday 26 September 2023.\n \nInvestor Presentation\nJulian Baines, Executive Chair, and Steve Young, Chief Financial Officer, will be hosting a live online presentation relating to the interim results via the Investor Meet Company platform at 5.30 pm on Tuesday 26 September 2023. The presentation is open to all existing and potential investors.\n \nInvestors can sign up to Investor Meet Company for free and register for the presentation here: \nhttps://www.investormeetcompany.com/ekf-diagnostics-holdings-plc/register-investor\n \nInvestors who already follow EKF on the Investor Meet Company platform will automatically be invited.\n \nA recording of the presentation, a PDF of the slides used, and responses to the Q&A session will be available on the Investor Meet Company platform afterwards.\n \n \n\n\n\nEKF Diagnostics Holdings plc\n\n\nwww.ekfdiagnostics.com\n\n\n\n\nJulian Baines, Executive Chair\n\n\n Tel: +44 (0)29 2071 0570\n\n\n\n\n\n\n\n\n\n\n\n\nSinger Capital Markets (Nominated Adviser & Broker)\n\n\nTel: +44 (0)20 7496 3000\n\n\n\n\nAubrey Powell / George Tzimas / Oliver Platts\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWalbrook PR Limited\n\n\nTel: +44 (0)20 7933 8780 or [email protected]\n\n\n\n\nPaul McManus / Lianne Applegarth\n\n\nMob: +44 (0)7980 541 893 / +44 (0)7584 391 303\n\n\n\n\n\n\n\n\n\n \nAbout EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)\n \nEKF is an AIM-listed global diagnostics business focussed on:\n \n·    Point-of-Care analysers in the key areas of Hematology and Diabetes, as well as Central Laboratory products including clinical chemistry reagents, analysers and centrifuges\n \n·    Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications, as well as other higher value Contract Manufacturing services\n \nEKF has headquarters in Penarth (near Cardiff) and operates five man...

More updates from Ekf Diagnostics Holdings Plc